100911-22-6

Basic information

• Product Name: Pyrrole, 1-(2-methylaminoethyl)- (6CI)
• Synonyms: Pyrrole, 1-(2-methylaminoethyl)- (6CI);N-methyl-2-(1H-pyrrol-1-yl)ethanamine;N-methyl-2-(1H-pyrrol-1-yl)ethan-1-amine;EOS-60464
• CAS NO: 100911-22-6
• Molecular Formula: C7H12N2
• Molecular Weight: 124.18358
• Product Categories: AMINETERTIARY
• Mol File: 100911-22-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Pyrrole, 1-(2-methylaminoethyl)- (6CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Pyrrole, 1-(2-methylaminoethyl)- (6CI)(100911-22-6)
• EPA Substance Registry System: Pyrrole, 1-(2-methylaminoethyl)- (6CI)(100911-22-6)

Safety Data

• Hazardous Substances Data: 100911-22-6(Hazardous Substances Data)

Upstream product

• 79108-74-0 1-(2-Formylaminoethyl)-pyrrole 
• 86241-05-6 2-(1H-pyrrol-1-yl)acetonitrile 
• 29709-35-1 1-(2-aminoethyl)pyrrole 
• 77200-24-9 1-(2-chloroethyl)-1H-pyrrole 
• 74-89-5 methylamine 

Downstream Products

• 1392291-33-6 (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'H-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone 

Relevant articles and documents

SOLID FORMS OF (4-ISOPROPOXY-3-METHOXYPHENYL)(2'-METHYL-6'-(TRIFLUOROMETHYL)-3',4'-DIHYDRO-2'H-SPIRO[PIPERIDINE-4,1'-PYRROLO[1,2-A]PYRAZINE]-1-YL)METHANONE

The invention relates to solid state forms, for example, crystalline forms, of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3,,4'- dihydro-2'H-spiro[piperidine-4, 1 '-pyrrolo[ 1,2-a]pyrazine]- 1 -yl)methanone (Compound 1) or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods therewith. The present invention also relates to a method of preparing Compound 1 in various solid forms. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders such as pain.

PYRROLOPYRAZINE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS

The invention relates to pyrrolopyrazine-spirocyclic piperidine amide compounds useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.